AG真人官方

KalVista Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2025

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)-- KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the Company will participate in a fireside chat at the Cantor Global Healthcare Conference 2025 on Wednesday, September 3, 2025, at 10:55 a.m. ET.

A live webcast of the presentation will be available on the Company鈥檚 website at . An audio archive will be available on KalVista鈥檚 website for 30 days following the presentation.

About KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc., is a global biopharmaceutical company dedicated to developing and delivering life-changing oral therapies for individuals affected by rare diseases with significant unmet needs. In the U.S., KalVista markets EKTERLY^庐, the first and only oral on-demand treatment for hereditary angioedema (HAE). The Company has multiple regulatory applications under review in key global markets. For more information about KalVista, please visit and follow us on , , and .

View source version on businesswire.com:

Investors:

Ryan Baker

Head, Investor Relations

(617) 771-5001

[email protected]

Media:

Molly Cameron

Director, Corporate Communications

(857) 356-0164

[email protected]

Source: KalVista Pharmaceuticals, Inc.